OptimizeRx Corporation (OPRX): Price and Financial Metrics
OPRX Price/Volume Stats
| Current price | $9.32 | 52-week high | $16.65 |
| Prev. close | $9.35 | 52-week low | $6.92 |
| Day low | $9.17 | Volume | 298,800 |
| Day high | $9.56 | Avg. volume | 121,675 |
| 50-day MA | $13.30 | Dividend yield | N/A |
| 200-day MA | $11.53 | Market Cap | 169.47M |
OPRX Stock Price Chart Interactive Chart >
OptimizeRx Corporation (OPRX) Company Bio
OptimizeRx Corporation operates an Internet website through which it offers advice to consumers on how to save money on branded prescription and over-the-counter healthcare products.
Latest OPRX News From Around the Web
Below are the latest news stories about OPTIMIZERX CORP that investors may wish to consider to help them evaluate OPRX as an investment opportunity.
Should You Exit OptimizeRx Corp. (OPRX)?Wasatch Global Investors, an investment management firm, released its “Wasatch Micro Cap Value Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark during the quarter. The quality-oriented positioning was the main reason for the strategy’s outperformance in the quarter. In addition, please check the fund’s […] |
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San FranciscoWALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that executives from the Company will be presenting and participating in one-on-ones at the 42nd Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA from January 8-11, 2024. The OptimizeRx presentation will take |
OptimizeRx Corp. (OPRX) Upgraded to Buy: What Does It Mean for the Stock?OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
With 74% institutional ownership, OptimizeRx Corporation (NASDAQ:OPRX) is a favorite amongst the big gunsKey Insights Given the large stake in the stock by institutions, OptimizeRx's stock price might be vulnerable to their... |
Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should KnowThe consensus price target hints at a 41.3% upside potential for OptimizeRx Corp. (OPRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
OPRX Price Returns
| 1-mo | -23.86% |
| 3-mo | -37.70% |
| 6-mo | 12.15% |
| 1-year | -39.36% |
| 3-year | -80.69% |
| 5-year | -23.10% |
| YTD | -34.87% |
| 2023 | -14.82% |
| 2022 | -72.95% |
| 2021 | 99.33% |
| 2020 | 203.41% |
| 2019 | -6.38% |
Continue Researching OPRX
Here are a few links from around the web to help you further your research on OptimizeRx Corp's stock as an investment opportunity:OptimizeRx Corp (OPRX) Stock Price | Nasdaq
OptimizeRx Corp (OPRX) Stock Quote, History and News - Yahoo Finance
OptimizeRx Corp (OPRX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...